Market Place
Sourcing Support
Neurophth Announces Completion of Patient Enrollment for Opvika Phase I/II Trial
19 Feb 2024 //
PR NEWSWIRE
Neurophth Announces First Patient Dosed in Ph I/II Trial of Second Gene Therapy
17 Aug 2023 //
PR NEWSWIRE
Neurophth Secures $95M in Series C+ Financing for Clinical Trials
14 Aug 2023 //
CONTRACT PHARMA
Neurophth Completes Enrollment for PIII trial for gene therapy treatment of LHON
21 Feb 2023 //
PR NEWSWIRE
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON
19 Dec 2022 //
PRNEWSWIRE
Cyagen and Neurophth partner to develop gene therapy vectors
08 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
China CDE Grants BTD to Neurophth`s NR082 in LHON
15 Jul 2022 //
PRNEWSWIRE
EMA Grants ODD to Neurophth Tx` NR082
25 Jan 2022 //
PRNEWSWIRE
Neurophth Tx Receives IND Clearance to Initiate Trial for NR082 in LHON
19 Jan 2022 //
PRNEWSWIRE
Neurophth Raised Over $60M USD in Series-C Financing to Advance Gene Therapies
23 Nov 2021 //
PRNEWSWIRE
Neurophth Biotechnology Opens Manufacturing Facility in Suzhou, China
29 Sep 2021 //
CONTRACTPHARMA
Neurophth launches GMP Manufacturing Facility for Gene Therapy in China
28 Sep 2021 //
BIOSPECTRUMASIA
Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic
02 Apr 2021 //
PRNASIA
Neurophth Announces IND Approval by the NMPA for Leber Hereditary
01 Apr 2021 //
PRNEWSWIRE
Neurophth Announces IND Approval by the NMPA for Leber Hereditary
01 Apr 2021 //
PRNEWSWIRE
Neurophth snags University of Louisville prof as new CSO
27 Jan 2021 //
FIERCEBIOTECH
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise
27 Jan 2021 //
PRNASIA
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership
20 Jan 2021 //
PRNEWSWIRE
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership
18 Jan 2021 //
PRNEWSWIRE
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next
18 Jan 2021 //
OAOA
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership
18 Jan 2021 //
PRNASIA
Neurophth Therapeutics` NR082 was Granted Orphan Drug Designation by USFDA
25 Sep 2020 //
PRNASIA
US FDA Approved Jemincare to Initiate Trial of Antibody JMB2002
05 Apr 2020 //
PRNASIA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.